Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses

Basic Research in Cardiology

Volumn 109, Issue 3, 2014, Pages

  Jenke, A ^a   Holzhauser, L ^a   Lobel M ^a   Savvatis, K ^a   Wilk, S ^a   Weithauser A ^a   Pinkert, S ^b   Tschope C ^a   Klingel, K ^c   Poller, W ^a   Scheibenbogen, C ^a   Schultheiss, H P ^a   Skurk, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Adiponectin; Coxsackievirus B3; Innate immunity; Myocarditis; Toll like receptor

Indexed keywords

ADIPONECTIN; BETA INTERFERON; CD14 ANTIGEN; CD3 ANTIBODY; CD4 ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; COXSACKIE VIRUS B3; DISEASE ASSOCIATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MOUSE; NATURAL KILLER CELL; NEWBORN; NONHUMAN; POLARIZATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; VIRAL CLEARANCE; VIRUS LOAD; VIRUS MYOCARDITIS; VIRUS REPLICATION;

COXSACKIEVIRUS INFECTIONS; MYOCARDITIS; ADIPONECTIN; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; KILLER CELLS, NATURAL; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; NECROSIS; RATS; RATS, WISTAR; TOLL-LIKE RECEPTORS; VENTRICULAR FUNCTION, LEFT; VIRAL LOAD;

EID: 84897119727     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-014-0408-y     Document Type: Article

References (47)

1. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU (1999) Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5:320-326. doi:10.1038/6543 (Pubitemid 29124369)
2. Blyszczuk P, Kania G, Dieterle T, Marty RR, Valaperti A, Berthonneche C, Pedrazzini T, Berger CT, Dirnhofer S, Matter CM, Penninger JM, Luscher TF, Eriksson U (2009) Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ Res 105:912-920. doi:10.1161/CIRCRESAHA.109.199802
3. Bobbert P, Scheibenbogen C, Jenke A, Kania G, Wilk S, Krohn S, Stehr J, Kuehl U, Rauch U, Eriksson U, Schultheiss HP, Poller W, Skurk C (2011) Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control. Eur Heart J 32:1134-1147. doi:10.1093/eurheartj/ehq498
4. Chiang CH, Lai JS, Hung SH, Lee LT, Sheu JC, Huang KC (2013) Serum adiponectin levels are associated with hepatitis B viral load in overweight to obese hepatitis B virus carriers. Obesity 21:291-296. doi:10.1002/oby.20000
5. Chow LH, Beisel KW, McManus BM (1992) Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest 66:24-31
6. Cooper LT Jr (2009) Myocarditis. N Eng J Med 360:1526-1538. doi:10.1056/NEJMra0800028
7. Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN (2004) Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110:3540-3543. doi:10.1161/01.CIR.0000136824.73458.20 (Pubitemid 39612568)
8. Esfandiarei M, McManus BM (2008) Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 3:127-155. doi:10.1146/annurev.pathmechdis.3. 121806.151534 (Pubitemid 351488278)
9. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Steele RA, Gatewood SJ, Rose NR (2005) IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol 174:261-269 (Pubitemid 40007412)
10. Finberg RW, Kurt-Jones EA (2006) CD14: chaperone or matchmaker? Immunity 24:127-129. doi:10.1016/j.immuni.2006.01.010 (Pubitemid 43214581)
11. Fujiu K, Nagai R (2013) Contributions of cardiomyocyte-cardiac fibroblast-immune cell interactions in heart failure development. Basic Res Cardiol 108:1-15. doi:10.1007/s00395-013-0357-x
12. Gebhard JR, Perry CM, Harkins S, Lane T, Mena I, Asensio VC, Campbell IL, Whitton JL (1998) Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol 153:417-428. doi:10.1016/S0002-9440(10)65585-X (Pubitemid 28373653)
13. Godeny EK, Gauntt CJ (1986) Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J Immunol 137:1695-1702 (Pubitemid 16014826)
14. Gorbea C, Makar KA, Pauschinger M, Pratt G, Bersola JL, Varela J, David RM, Banks L, Huang CH, Li H, Schultheiss HP, Towbin JA, Vallejo JG, Bowles NE (2010) A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem 285:23208-23223. doi:10.1074/jbc.M109.047464
15. Hofmann U, Frantz S (2013) How can we cure a heart "in flame"? A translational view on inflammation in heart failure. Basic Res Cardiol 108:1-19. doi:10.1007/s00395-013-0356-y
16. Jenke A, Wilk S, Poller W, Eriksson U, Valaperti A, Rauch BH, Stroux A, Liu P, Schultheiss HP, Scheibenbogen C, Skurk C (2013) Adiponectin protects against Toll-like receptor 4 mediated cardiac inflammation and injury. Cardiovasc Res 99:422-431. doi:10.1093/cvr/cvt118
17. Kanda T, Saegusa S, Takahashi T, Sumino H, Morimoto S, Nakahashi T, Iwai K, Matsumoto M (2007) Reduced-energy diet improves survival of obese KKAy mice with viral myocarditis: induction of cardiac adiponectin expression. Int J Cardiol 119:310-318. doi:10.1016/j.ijcard.2006.07.181 (Pubitemid 46921251)
18. Kandolf R, Sauter M, Aepinus C, Schnorr JJ, Selinka HC, Klingel K (1999) Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system. Virus Res 62:149-158. doi:10.1016/S0168-1702(99) 00041-6 (Pubitemid 29393115)
19. Kania G, Blyszczuk P, Eriksson U (2009) Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovas Med 19:247-252. doi:10.1016/j.tcm.2010.02.005
20. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, Lindinger A, Bohm M (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639-648. doi:10.1161/CIRCULATIONAHA.108.769489
21. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. PNAS 89:314-318. doi:10.1073/pnas.89.1.314
22. Kuhl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with " idiopathic" left ventricular dysfunction. Circulation 111:887-893. doi:10.1161/01.CIR.0000155616.07901.35 (Pubitemid 40279890)
23. Kuhl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107:2793-2798. doi:10.1161/01.CIR.0000072766.67150.51 (Pubitemid 36705988)
24. Lamphear BJ, Yan R, Yang F, Waters D, Liebig HD, Klump H, Kuechler E, Skern T, Rhoads RE (1993) Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. J Biol Chem 268:19200-19203 (Pubitemid 23270688)
25. Meznarich J, Malchodi L, Helterline D, Ramsey SA, Bertko K, Plummer T, Plawman A, Gold E, Stempien-Otero A (2013) Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages. PLoS One 8:e57837. doi:10.1371/journal.pone.0057837
26. Negishi H, Osawa T, Ogami K, Ouyang X, Sakaguchi S, Koshiba R, Yanai H, Seko Y, Shitara H, Bishop K, Yonekawa H, Tamura T, Kaisho T, Taya C, Taniguchi T, Honda K (2008) A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. PNAS 105:20446-20451. doi:10.1073/pnas.0810372105
27. Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, Gokce N, Pedersen AA, Kalthoff C, Tullin S, Sams A, Summer R, Walsh K (2010) Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 285:6153-6160. doi:10.1074/jbc.M109.088708
28. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102:1296-1301
29. Pei H, Qu Y, Lu X, Yu Q, Lian K, Liu P, Yan W, Liu J, Ma Y, Liu Y, Li C, Li W, Lau W, Zhang H, Tao L (2012) Cardiac-derived adiponectin induced by long-term insulin treatment ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic mice via AMPK signaling. Basic Res Cardiol 108:1-11. doi:10.1007/s00395-012-0322-0
30. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, Dieli F, Ghisletti S, Natoli G, De Baetselier P, Mantovani A, Sica A (2009) Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. PNAS 106:14978-14983. doi:10.1073/pnas.0809784106
31. Riad A, Westermann D, Zietsch C, Savvatis K, Becher PM, Bereswill S, Heimesaat MM, Lettau O, Lassner D, Dorner A, Poller W, Busch M, Felix SB, Schultheiss HP, Tschope C (2011) TRIF is a critical survival factor in viral cardiomyopathy. J Immunol 186:2561-2570. doi:10.4049/jimmunol.1002029
32. Shibata R, Izumiya Y, Sato K, Papanicolaou K, Kihara S, Colucci WS, Sam F, Ouchi N, Walsh K (2007) Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 42:1065-1074. doi:10.1016/j.yjmcc.2007.03.808 (Pubitemid 46829193)
33. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK-and COX-2-dependent mechanisms. Nat Med 11:1096-1103. doi:10.1038/nm1295 (Pubitemid 41486832)
34. Takahashi T, Saegusa S, Sumino H, Nakahashi T, Iwai K, Morimoto S, Kanda T (2005) Adiponectin replacement therapy attenuates myocardial damage in leptin-deficient mice with viral myocarditis. Journal Int Med Res 33:207-214. doi:10.1177/147323000503300208 (Pubitemid 40372436)
35. Takahashi T, Yu F, Saegusa S, Sumino H, Nakahashi T, Iwai K, Morimoto S, Kurabayashi M, Kanda T (2006) Impaired expression of cardiac adiponectin in leptin-deficient mice with viral myocarditis. Int Heart J 47:107-123. doi:10.1536/ihj.47.107
36. Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6:772-783. doi:10.1038/nri1937 (Pubitemid 44453463)
37. Trapani JA, Smyth MJ (2002) Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2:735-747. doi:10.1038/nri911 (Pubitemid 37328714)
38. Wada H, Saito K, Kanda T, Kobayashi I, Fujii H, Fujigaki S, Maekawa N, Takatsu H, Fujiwara H, Sekikawa K, Seishima M (2001) Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: a study using mice lacking TNF-alpha. Circulation 103:743-749 (Pubitemid 32144205)
39. Wessely R, Klingel K, Knowlton KU, Kandolf R (2001) Cardio-selective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 103:756-761 (Pubitemid 32144207)
40. Wilk S, Jenke A, Stehr J, Yang CA, Bauer S, Goldner K, Kotsch K, Volk HD, Poller W, Schultheiss HP, Skurk C, Scheibenbogen C (2013) Adiponectin modulates natural killer cell function. Eur J Immunol 43:1024-1033. doi:10.1002/eji. 201242382
41. Wilk S, Scheibenbogen C, Bauer S, Jenke A, Rother M, Guerreiro M, Kudernatsch R, Goerner N, Poller W, Elligsen-Merkel D, Utku N, Magrane J, Volk HD, Skurk C (2011) Adiponectin is a negative regulator of antigen-activated T cells. Eur J Immunol 41:2323-2332. doi:10.1002/eji.201041349
42. Woodruff JF, Woodruff JJ (1974) Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease. J Immunol 113:1726-1734
43. Xiong D, Lee GH, Badorff C, Dorner A, Lee S, Wolf P, Knowlton KU (2002) Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease. Nat Med 8:872-877. doi:10.1038/nm737
44. Yajima T, Knowlton KU (2009) Viral myocarditis: from the perspective of the virus. Circulation 119:2615-2624. doi:10.1161/CIRCULATIONAHA.108.766022
45. Yan W, Zhang H, Liu P, Wang H, Liu J, Gao C, Liu Y, Lian K, Yang L, Sun L, Guo Y, Zhang L, Dong L, Lau W, Gao E, Gao F, Xiong L, Wang H, Qu Y, Tao L (2013) Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart. Basic Res Cardiol 108:1-15. doi:10.1007/s00395-013-0329-1
46. Yoon S, Jung J, Kim T, Park S, Chwae YJ, Shin HJ, Kim K (2011) Adiponectin, a downstream target gene of peroxisome proliferator-activated receptor gamma, controls hepatitis B virus replication. Virology 409:290-298. doi:10.1016/j.virol.2010.10.024
47. Zacharioudaki V, Androulidaki A, Arranz A, Vrentzos G, Margioris AN, Tsatsanis C (2009) Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression. J Immunol 182:6444-6451. doi:10.4049/jimmunol. 0803694